Panacea Biotec Ltd.

BSE: 531349 | NSE: PANACEABIO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE922B01023 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Panacea Biotec Panacea Biotec Ltd. | BSE 388.45 -9.00 (-2.26%) | NSE 386.55 -9.75 (-2.46%) | Trade | Add

BSE Live

Dec 30, 16:01

388.45 -9.00 (-2.26%)

Volume

AVERAGE VOLUME

5-Day

934,545

10-Day

469,607

30-Day

160,854

148,411

Prev. Close

397.45
Open Price

400.00

Bid Price (Qty.)
381.10 (500)
Offer Price (Qty.)
383.40 (10)

NSE Live

Dec 30, 15:56

386.55 -9.75 (-2.46%)

Volume

AVERAGE VOLUME

5-Day

8,114,818

10-Day

4,074,303

30-Day

1,448,547

1,902,463

Prev. Close

396.30
Open Price

399.40

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
386.55 (8207)

Financials

Print/Copy to Excel : Go

Balance Sheet of Panacea Biotec (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	6.13	6.13	6.13	6.13	6.13
Total Share Capital	22.43	6.13	6.13	6.13	6.13
Reserves and Surplus	448.76	506.59	619.56	866.94	642.73
Total Reserves and Surplus	448.76	506.59	619.56	866.94	642.73
Total Shareholders Funds	471.19	512.72	625.69	873.07	648.86
Minority Interest	3.42	5.48	7.35	6.60	6.40
NON-CURRENT LIABILITIES
Long Term Borrowings	722.97	583.17	689.91	512.52	423.72
Deferred Tax Liabilities [Net]	0.48	0.52	0.48	20.73	75.82
Other Long Term Liabilities	14.59	2.91	3.54	13.84	0.00
Long Term Provisions	11.69	2.02	2.53	2.07	2.99
Total Non-Current Liabilities	749.73	588.62	696.46	549.16	502.53
CURRENT LIABILITIES
Short Term Borrowings	295.84	320.67	274.00	249.54	363.94
Trade Payables	209.13	252.11	175.69	122.21	97.38
Other Current Liabilities	194.85	251.91	49.82	137.10	101.62
Short Term Provisions	6.21	11.84	10.45	10.05	13.12
Total Current Liabilities	706.03	836.53	509.96	518.90	576.06
Total Capital And Liabilities	1,930.47	1,943.35	1,839.46	1,949.78	1,733.85
ASSETS
NON-CURRENT ASSETS
Tangible Assets	1,116.52	1,238.19	1,105.18	1,142.74	668.63
Intangible Assets	27.78	37.35	49.31	52.36	16.11
Capital Work-In-Progress	143.20	160.12	124.62	55.85	36.55
Fixed Assets	1,299.78	1,448.02	1,289.75	1,285.93	803.63
Non-Current Investments	10.20	15.94	16.51	30.91	56.58
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	94.69	98.02	99.28	101.90	56.67
Other Non-Current Assets	0.08	0.35	0.17	6.54	3.30
Total Non-Current Assets	1,404.75	1,562.33	1,405.71	1,425.28	920.18
CURRENT ASSETS
Current Investments	4.98	0.03	5.99	1.60	0.09
Inventories	310.22	219.81	267.94	385.26	410.63
Trade Receivables	98.57	94.93	69.86	68.38	275.57
Cash And Cash Equivalents	52.40	24.78	39.23	15.51	48.94
Short Term Loans And Advances	53.19	37.35	46.94	48.34	70.92
OtherCurrentAssets	6.36	4.12	3.79	5.41	7.52
Total Current Assets	525.72	381.02	433.75	524.50	813.67
Total Assets	1,930.47	1,943.35	1,839.46	1,949.78	1,733.85
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00
BONUS DETAILS
Bonus Equity Share Capital	1.81	1.81	1.81	1.81	1.81
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.01	0.01	0.01	16.57	29.50
Non-Current Investments Unquoted Book Value	10.12	15.93	16.50	16.48	26.57
CURRENT INVESTMENTS
Current Investments Quoted Market Value	4.98	0.03	5.99	1.61	0.09
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00